Common Contracts
5 similar Separation and Release of Claims Agreement contracts by Nabriva Therapeutics PLC
SEPARATION AND RELEASE OF CLAIMS AGREEMENTSeparation and Release of Claims Agreement • July 7th, 2023 • Nabriva Therapeutics PLC • Pharmaceutical preparations • Pennsylvania
This Separation and Release of Claims Agreement (the “Agreement”) is made as of the Agreement Effective Date (as defined below) between Nabriva Therapeutics US, Inc. (the “Company”) and J. Christopher Naftzger (the “Executive”) (together, the “Parties”).
SEPARATION AND RELEASE OF CLAIMS AGREEMENTSeparation and Release of Claims Agreement • July 7th, 2023 • Nabriva Therapeutics PLC • Pharmaceutical preparations • Pennsylvania
This Separation and Release of Claims Agreement (the “Agreement”) is made as of the Agreement Effective Date (as defined below) between Nabriva Therapeutics US, Inc. (the “Company”) and Daniel Dolan (the “Executive”) (together, the “Parties”).
SEPARATION AND RELEASE OF CLAIMS AGREEMENTSeparation and Release of Claims Agreement • April 17th, 2023 • Nabriva Therapeutics PLC • Pharmaceutical preparations • Pennsylvania
This SEPARATION AND RELEASE OF CLAIMS AGREEMENT (the “Agreement”) is made as of the Agreement Effective Date (as defined below) between Nabriva Therapeutics US, Inc. (the “Company”) and Christine Guico-Pabia (“Executive”) (together, the “Parties”).
SEPARATION AND RELEASE OF CLAIMS AGREEMENTSeparation and Release of Claims Agreement • January 20th, 2023 • Nabriva Therapeutics PLC • Pharmaceutical preparations • Pennsylvania
This Separation and Release of Claims Agreement (the “Agreement”) is made as of the Agreement Effective Date (as defined below) between Nabriva Therapeutics US, Inc. (the “Company”) and Steven Gelone (“Executive”) (together, the “Parties”).
SEPARATION AND RELEASE OF CLAIMS AGREEMENTSeparation and Release of Claims Agreement • January 20th, 2023 • Nabriva Therapeutics PLC • Pharmaceutical preparations • Pennsylvania
This Separation and Release of Claims Agreement (the “Agreement”) is made as of the Agreement Effective Date (as defined below) between Nabriva Therapeutics US, Inc. (the “Company”) and Theodore R. Schroeder (“Executive”) (together, the “Parties”).
